Submitted:
12 April 2020
Posted:
14 April 2020
Read the latest preprint version here
Preprints on COVID-19 and SARS-CoV-2
Abstract
Recent reports suggest that the clinical course of coronavirus disease 2019 (COVID-19) in previously healthy children is usually milder as compared to adults. However, children with co-morbid conditions such as diabetes are at increased risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as well as morbidity and mortality due to COVID-19. Experience in adults with diabetes shows that they are prone to faster metabolic decompensation, develop diabetes-related complications and have a poor prognosis when hospitalised with COVID-19. The data in children is limited. The aim of this mini-review is to discuss the possible risks to children and adolescents with diabetes during the current pandemic and the special considerations in management in those affected with COVID-19.
Keywords:
Coronavirus disease 2019
; COVID-19
; children
; diabetes
; type 1 diabetes
; type 2 diabetes
; recommendations
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
